Delivery Order SPE2DR25D3101-SPE2DR26F5U80
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $12,950.84 Firm Fixed Price Delivery Order is for the supply of 4,567,262,479 units of Allopurinol Sodium 500 mg vials, with a completion date of February 6, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This delivery order for allopurinol tablets was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation. The firm fixed price contract has a potential value of one hundred seventy-four dollars and requires delivery of five hundred allopurinol tablets by October 6, 2023 to a location in Conshohocken, Pennsylvania. No set-aside provisions were applied to this procurement. As the Defense Logistics Agency is responsible for worldwide logistics support of the Department of...
- The Defense Logistics Agency awarded a $48,620 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 bottles of 300mg allopurinol tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order runs from July 24, 2023 through July 25, 2023 to supply the Defense Logistics Agency with the specified pharmaceutical product. No major subcontractors or set aside designations were identified. The Defense Logistics Agency...
- The Defense Logistics Agency awarded a $1,912.24 delivery order to AmerisourceBergen Drug Corp for Uloric 40 mg tablets (30-count) on September 19, 2025, with a completion date of September 22, 2025. This competitively awarded, firm fixed-price contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The prime vendor agreement serves as a comprehensive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,580.18 to AmerisourceBergen Drug Corp for the supply of Uloric 80 mg tablets (30-count units) under a firm fixed-price contract type. The award was issued on July 29, 2025, with an ultimate completion date of July 30, 2025, and is classified as a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,353.24 on December 8, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (120-count package). This is a firm fixed-price delivery order with no set-aside designation, reflecting open competition, and is scheduled for completion by December 9, 2025. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.66 to AmerisourceBergen Drug Corp for the supply of Febuxostat 80 mg tablets (30-count) on November 3, 2025, with completion expected by November 4, 2025. This firm fixed price contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (90-count units) with a ceiling value of $1,541.01. This is a firm fixed-price delivery order with no set-aside designation, completed competitively under open procurement requirements. The contract calls for delivery to Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Febuxostat 80 mg tablets in quantities of 30, with a contract value of $2,176.51 and a firm fixed price structure. This non-set-aside delivery order, which is expected to be completed by November 26, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,571.86 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count units) on December 18, 2025, with an ultimate completion date of December 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5U80Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Allopurinol 100 mg tablets in quantities of 1,000 units at a firm fixed price of $1,171.75. The contract, which is not set-aside and was competitively awarded, is scheduled for completion by December 24, 2025, with performance at the contractor's Conshohocken, Pennsylvania headquarters. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, leverages this broad IDC to supply a diverse range of pharmaceutical products and medical supplies to military healthcare systems and other federal agencies. The company's extensive contract portfolio with DLA demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This particular delivery order for Allopurinol, a commonly used gout medication, reflects the routine pharmaceutical supply operations executed under the parent IDC framework that supports Defense Health Agency and U.S. Coast Guard healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/22/25 |